AuntMinnie.com staff writersAIFDA issues discussion paper on GenAI medical devicesThe paper covers risk assessment, pre-market evaluation, and considerations around foundation models and agentic AI systems.August 18, 2026Enterprise ImagingNewVue partners with Strategic Radiology on workflow platform accessStrategic Radiology's member practices now have preferred access to NewVue's radiology workflow platform.August 18, 2026Digital X-RayRayence launches portable x-ray systemsThe Anywhere-M and Anywhere-V systems are designed for point-of-care use in humans and animals, respectively.August 18, 2026People in the NewsGEHC names new CFOGE HealthCareWilliam Grogan, executive vice president and CFO of Xylem, will succeed Jay Saccaro.August 18, 2026CTAzra AI, 4DMedical enter partnership4DMedical will integrate CT:VQ, its quantitative lung imaging analytics software, with Azra AI's platform.August 17, 2026BreastCureMetrix secures FDA clearance for cmAngio 2.0The update introduces BAC quantification, age-based BAC percentile scoring compared against a reference library of more than 170,000 studies.August 17, 2026Enterprise ImagingEpic adds one-click diagnostic image exchangeClinicians at Epic health systems can retrieve the images with a single click.August 17, 2026Molecular ImagingLantheus wins FDA approval for tau PET imaging agentTauklarify, previously known as MK-6240, has been approved for tau PET imaging in adults with cognitive impairment being evaluated for Alzheimer's disease.August 14, 2026PACS/VNALG gets FDA nod for 40-inch ultrawide diagnostic monitorLGThe monitor supports side-by-side review of x-ray, CT, or MRI images alongside electronic medical records on a single screen.August 13, 2026Radiation Oncology/TherapyASTRO updates radiation therapy guideline for pancreatic cancerThe guide outlines when and how radiation therapy and chemoradiation should be used to treat different forms of prostate cancer.August 13, 2026Previous PagePage 2 of 289Next PageTop StoriesMolecular ImagingPET/CT outperforms MRI after focal therapy for prostate cancerNo accurate noninvasive method has been validated to evaluate treatment response after focal therapy.Practice ManagementFlorida approves NBPAS as recognized board certification optionInterventionalThermal ablation achieves long-term survival in kidney cancerAIMost FDA-cleared AI medical devices not tested on patient outcomesSponsor ContentNominations Are Open — 2026 Minnies